Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Clinical trial NCT03298867 · COMPLETED
Trial details
- NCT number
- NCT03298867
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2019-02-13
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.